• 11 April 2005
  • News
  • By


Bangalore BIO 2005
The Department of IT and Biotechnology, Government of Karnataka and Vision Group on Biotechnology will jointly organize Bangalore BIO 2005 from April 22-24, 2005. The core theme of the conference will be 'Bio-technology for billion people.' The three-day conference will be addressed by over 50 speakers from all across the globe. About 700 delegates are expected to attend the conference.
For further details, contact: info@bangalorebio2005.com  or biodir@bangalorebio.com  or ceo@kbdc.org

BIO 2005
Biotechnology Industry Organization's (BIO) 2005 Annual International Convention will be held at the Pennsylvania Convention Center in Philadelphia on June 19-22, 2005. This year's conference is hosted by the tri-state region of Pennsylvania, New Jersey, and Delaware. More than 18,000 biotech executives, investors, journalists, policy makers and scientists from more than 60 countries are expected to attend.

The convention will feature greater overseas representation with two international plenary sessions, country seminars with 16 countries presenting the latest developments in national biotechnology policies, and a ministerial seminar with federal level ministers from at least four countries. BIO will host a record number of high ranking international dignitaries leading national delegations from more than 60 countries. The program includes more than 150 educational sessions and workshops on topics including industrial and environmental applications, finance, science, manufacturing, food and agriculture.
For more details, contact: info@bio.org

BIO VentureForum East 2005
The Biotechnology Industry Organization (BIO), in partnership with 12 state biotechnology associations and BIOTECanada will organize BIO VentureForum East 2005 at the Intercontinental Hotel-Buckhead, Atlanta, Georgia on May 9-11, 2005. The conference will bring venture capitalists together with promising seed, early- and late-stage private biotechnology product and platform companies from the East Coast. It will showcase 120 individual company presentations to leading North American venture capital firms in the life sciences field. Workshops and plenary sessions will be offered on trends in the biotech industry, with special focus on key success factors for early stage companies, R&D, market trends, and financing. In addition, there will be formal and informal networking opportunities with industry CEOs and venture capital leaders.

To ensure high quality deal flow, an advisory board made up of 30 equity capital leaders, will review and evaluate the corporate profiles of companies through an application process. Selected entrepreneurs will also attend regional BIO Venture Forum Boot Camps to be intensively coached and provided with the tools needed to refine their presentations and grow their enterprises.
For more details, contact: gbutera@bio.org  or ccook@bio.org

World Congress on Industrial Biotechnology
The Biotechnology Industry Organization (BIO), American Chemical Society (ACS) and the National Agriculture Biotechnology Council (NABC) will organise the second annual World Congress on Industrial Biotechnology and Bioprocessing on April 20-22 in Orlando, Florida. The conference will be geared toward a diverse base of participants from biotechnology, chemical and other industries, to government and academia. It is meant to provide a unique forum for interdisciplinary interaction and networking. The three-day event will feature technical sessions for business, academic and research-related presentations on topics such as biotechnology in manufacturing and synthesis and industrial biotech in pharmaceuticals.
For further details, contact: worldcongress@bio.org

BioSquare 2005
BioSquare 2005, a three-day event which will commence on April 13, 2005, will offer a unique opportunity for the top management of biotechnology companies to meet with key research and business development executives from the pharmaceutical, nutraceutical, agriculture, food, and finance industries. BioSquare will be held on the occasion of the next World Life Sciences Forum, BioVision 2005. BioSquare and BioVision will take place in conjunction with several other events such as the Nobel Laureates' Day, BioVision.Nxt and Europ@BioVision.The unique combination of these events represents the largest gathering at the highest level of key opinion-leaders and decision-makers from the World of Life Sciences.
For more information, contact: tvoigt@ebdgroup.com

Bio-Collaborations Asia
IBC Life Sciences will organize Bio-Collaborations Asia at the Boston Park Plaza Hotel, Boston, MA, on May 18-20, 2005. The conference will explore the issues relating to building and growing a pharmaceutical or biotechnology business in Asia. It will feature select case experiences of US and European companies who have ventured into Asia, either through joint venture, licensing or outsourcing collaborations. Conference speakers will examine the challenges, the tribulations and the successes of these partnerships.

The conference will include focused sessions on IP and Regulatory concerns in China and India, value propositions for licensing, outsourcing and offshoring to Asia, best practices and case studies of successful collaborations between East and West.

IBC in association with The Federation of Indian Chambers of Commerce and Industry (FICCI) will also organize a half-day "India Pharma Forum 2005" on May 18, 2005.
For more details, contact: inq@ibcusa.com

Phacilitate Vaccine Forum Spring 2005
Phacilitate's fourth annual Spring Vaccine Forum will be held on May 23-25, 2005 at Amsterdam, Netherlands. The conference will provide an ideal opportunity for leaders from across the vaccines sector to meet, and to discuss solutions to their common strategic, regulatory and technological challenges. A blend of plenary presentations, workshops, breakout sessions and panel discussions will make for a highly interactive conference which will be complemented by networking over the course of the three days. The sessions will include discussion on overcoming major current challenges in the development and regulation of novel vaccines, vaccine safety reporting requirements and initiatives and programs related to clinical trial conduct.
For more details, contact: nathalie@phacilitate.co.uk

BIO-Windhover 2005
BIO and Windhover Information will jointly organise BIO-Windhover 2005 at The Ritz-Carlton Washington DC, on April 25-27, 2005. The conference will provide an exclusive platform for biotech and pharmaceutical business development decision makers to have focused, meaningful conversations about partnership opportunities. The conference will use a state-of-the-art scheduling software to facilitate one-on-one meetings between potential partners. Over 300 senior pharmaceutical and biotech business development executives are expected to attend the conference and over 1100 private, one-on-one meetings will be arranged through scheduling software.
For more details, contact: ccampbell@bio.org  or sgreenberg@windhover.com


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box


GST: Boon or Bane for Healthcare?

Send this article by email